China's National Medical Products Administration Approves the Country's First Drug for Preventing Acute Mountain Sickness

On August 6, 2026, China's National Medical Products Administration officially approved a sustained-release capsule for the prevention of acute mountain sickness. Officials claimed it fills a gap in domestic medication, but because the regimen has been used internationally for decades, it has sparked public questions about delays in the approval process.